Pages that link to "Q35107823"
Jump to navigation
Jump to search
The following pages link to A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. (Q35107823):
Displaying 50 items.
- Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures (Q24650880) (← links)
- Levetiracetam in the treatment of epilepsy (Q24656333) (← links)
- Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review (Q26743786) (← links)
- Safety of Levetiracetam in Paediatrics: A Systematic Review (Q26765160) (← links)
- Perampanel for focal epilepsy: insights from early clinical experience (Q26778392) (← links)
- Clinical pharmacology and pharmacokinetics of levetiracetam (Q27022582) (← links)
- Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register (Q30604685) (← links)
- Acute mania associated with levetiracetam treatment (Q33887278) (← links)
- Levetiracetam as an alternative therapy for Tourette syndrome (Q33966358) (← links)
- Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations (Q34186198) (← links)
- Negative effects of antiepileptic drugs on mood in patients with epilepsy (Q34580773) (← links)
- Levetiracetam for managing neurologic and psychiatric disorders (Q34957747) (← links)
- Clear indications of emotion depend on vivid stimuli (Q35478174) (← links)
- New drugs for the treatment of epilepsy: a practical approach (Q35520425) (← links)
- Psychiatric symptoms and quality of life in patients with drug-refractory epilepsy receiving adjunctive levetiracetam therapy (Q35539645) (← links)
- Epilepsy and cognition (Q35550771) (← links)
- Levetiracetam: treatment in epilepsy (Q35575012) (← links)
- Behavioural effects of the newer antiepileptic drugs: an update (Q35609738) (← links)
- Cognitive side effects of antiepileptic drugs (Q35630253) (← links)
- Levetiracetam safety profiles and tolerability in epilepsy patients. (Q35873716) (← links)
- Hallucination in a seizure patient using levetiracetam: a case report (Q36125182) (← links)
- Benefit-risk assessment of levetiracetam in the treatment of partial seizures (Q36265931) (← links)
- Catatonia induced by levetiracetam (Q36297027) (← links)
- Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy. (Q36703584) (← links)
- The safety of levetiracetam (Q36811528) (← links)
- Assessing the role of drugs in suicidal ideation and suicidality (Q36830144) (← links)
- Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures (Q36873888) (← links)
- Neuropsychological and behavioral effects of antiepilepsy drugs (Q36974353) (← links)
- Epilepsy pharmacogenetics (Q37486720) (← links)
- Psychopharmacological issues in the treatment of TBI and PTSD. (Q37625940) (← links)
- Adverse effects of antiepileptic drugs: a brief overview of important issues (Q37762256) (← links)
- Assessing the unmet treatment need in partial‐onset epilepsy: Looking beyond seizure control (Q37802905) (← links)
- Levetiracetam: a review of its use in epilepsy (Q37851959) (← links)
- Meta-Analysis of Randomized Trials on First Line and Adjunctive Levetiracetam (Q37868362) (← links)
- Psychiatric symptomatologies and disorders related to epilepsy and antiepileptic medications (Q37880900) (← links)
- Spotlight on levetiracetam in epilepsy (Q37936429) (← links)
- The long-term safety of antiepileptic drugs (Q38106856) (← links)
- Third International Congress on Epilepsy, Brain, and Mind: Part 2. (Q38564727) (← links)
- Cognitive and behavioral outcomes among seizure-controlled children with partial epilepsy on antiepileptic drug monotherapy (Q38806037) (← links)
- Diagnostic and therapeutic strategies for management of autoimmune encephalopathies. (Q38832800) (← links)
- Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior (Q41455479) (← links)
- Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy (Q42373817) (← links)
- Nonepileptic seizures under levetiracetam therapy (Q42863767) (← links)
- Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques (Q43287918) (← links)
- Levetiracetam in combined therapy for focal epilepsy: experience with 80 patients (Q44813155) (← links)
- Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects (Q44880533) (← links)
- The influence of comorbid depression on seizure severity (Q47365988) (← links)
- The influence of levetiracetam on psychosocial and behavioral functioning in children: A case-control and follow-up study (Q47868142) (← links)
- Psychiatric side effects and antiepileptic drugs: Observations from prospective audits (Q47874329) (← links)
- Levetiracetam use in critically ill patients (Q48118239) (← links)